Abstract
3-(Phenylcyclobutyl)-1,2,4-triazoles were identified as inhibitors of 11β-Hydroxysteroid Dehydrogenase Type 1 (HSD1). They were shown to be active in the mouse in vivo pharmacodynamic model (PD) for HSD1 but exhibited a potent off-target activation of the Pregnane X Receptor (PXR). SAR studies and synthesis of analogs that led to the discovery of a selective HSD1 inhibitor are described in detail.
| Original language | English |
|---|---|
| Pages (from-to) | 2141-2145 |
| Number of pages | 5 |
| Journal | Bioorganic and Medicinal Chemistry Letters |
| Volume | 21 |
| Issue number | 7 |
| DOIs | |
| State | Published - 1 Apr 2011 |
Keywords
- 11β-Hydroxysteroid Dehydrogenase Type 1
- Metabolic Syndrome
- Pregnane X Receptor
Fingerprint
Dive into the research topics of 'Substituted phenyl triazoles as selective inhibitors of 11β-hydroxysteroid dehydrogenase type 1'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver